APA (7th ed.) Citation

Shiba, K., Fujiwara, M., Onuki, A., Kato, D., Shirakawa, T., Shimizu, Y., . . . Yokoyama, M. Pembrolizumab for treatment-related neuroendocrine prostate carcinoma with a high tumor mutational burden: A case report. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Shiba, Keiji, et al. Pembrolizumab for Treatment-related Neuroendocrine Prostate Carcinoma with a High Tumor Mutational Burden: A Case Report. Frontiers Media S.A.

MLA (9th ed.) Citation

Shiba, Keiji, et al. Pembrolizumab for Treatment-related Neuroendocrine Prostate Carcinoma with a High Tumor Mutational Burden: A Case Report. Frontiers Media S.A.

Warning: These citations may not always be 100% accurate.